Related Experiment Video
Updated: Apr 22, 2026
14:56
The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
8.8K
[Multidrug-resistant germs in neurological early rehabilitation (2004-2013)]
J D Rollnik1, A-M Samady2, L Grüter2
1Institut für neurorehabilitative Forschung (InFo) der BDH-Klinik Hessisch Oldendorf, Akademisches Lehrkrankenhaus der Medizinischen Hochschule Hannover.
Die Rehabilitation
|October 16, 2014
Summary
Multidrug-resistant germs like MRSA and MRGN are prevalent in neurological rehabilitation, posing significant challenges. This study highlights the need for better data and financial support for affected patients.
Area of Science:
- Infectious Diseases
- Neurology
- Public Health
Context:
- Neurological and neurosurgical early rehabilitation settings face increasing challenges from multidrug-resistant organisms (MDROs).
- Limited reliable data exists on the prevalence of specific MDROs in these critical care environments.
- The BDH Clinic Hessisch Oldendorf in Germany serves as the study site for this 10-year observational analysis.
Purpose:
- To determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multidrug-resistant gram-negative germs (MRGN) in a German neurological early rehabilitation facility.
- To analyze trends and co-occurrence of these resistant pathogens over a decade (2004-2013).
- To underscore the clinical, financial, and ethical implications of MDROs in early neuro-rehabilitation.
Summary:
- MRSA prevalence on admission was 11.4%, and MRGN prevalence during rehabilitation was 11.8% over the 10-year study period.
- A combination of MRSA and MRGN was found in 3.8% of patients.
- VRE prevalence remained low at 0.1%, with initial detection in 2009.
Impact:
- High prevalence of MRSA and MRGN necessitates addressing significant financial, medical, and ethical concerns in rehabilitation facilities.
- The findings support the call for multi-center studies to gather more comprehensive data on MDROs in neuro-rehabilitation.
- Recommendations include improved financial compensation for patients with MDROs within the German DRG system.
More Related Videos
Related Concept Videos
01:30Specialized Care Centers and Settings-II
1.1K
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.1K
01:25Clinical Significance of Antibiotic Resistance
74
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
74
01:25Mechanism of Antibiotic Resistance in MRSA
180
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
180